Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Cambi: order intake and backlog rose sharply, profitability declining
Cambi reports a 22% revenue decline for Q2 2026 to NOK 265m and an EBITDA of NOK 26m; gross margin fell to 44%. Operating cash flow rose 44% to NOK 156m, order intake climbed to NOK 554m and the order backlog to NOK 1.5bn. Management expects lower operating profit in 2026 versus 2025 due to project mix and schedules of large contracts, but sees growth potential in the UK, India and New Zealand. The balance sheet remains solid with no long-term debt; however, about 25% of the backlog is conditional. » More on de.investing.com
Cambi Q3 2025: revenue down, order intake sharply increased
Cambi reports Q3 2025 revenue falling to 257 million NOK (Q3 2024: 277 million NOK) and an EBITDA of 42 million NOK (down 39% from 68 million NOK). Order intake climbed strongly to 422 million NOK (prior year 117 million NOK) and the order backlog rose to 1.1 billion NOK, while cash and cash equivalents stand at 224 million NOK. The company is introducing new products such as the thermal hydrolysis system Model E, expects a lower operating result for 2026 and announces further growth through international expansion and acquisitions. After the figures were released the stock fell slightly and is trading near its 52-week low. » More on de.investing.com
Cambi ASA: revenue rises, but falling margins weigh on stock
Cambi ASA reported a 12% increase in revenue to NOK 342m for Q2 2025; at the same time EBITDA fell 8% and the gross margin declined, prompting a sharp drop in the stock after the results. The order backlog remains robust at NOK 938m, the company acquired 51% of C and P Cycles and announced dividend payments, but it sees risks from weakening order intake and regulatory pressure. Management stresses continued underlying demand but expects revenue challenges in 2026. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 23.41M | 18.60% |
| Gross profit | 1.83M | 87.13% |
| Net profit | 1.48M | 80.51% |
| EBITDA | 2.31M | 63.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €331.46M |
Number of shares | 160.03M |
52-week high/low | €2.12 - €1.38 |
Dividend yield | 3.21% |
Dividends TTM | €0.0661 |
Beta | 0.79 |
P/E ratio | 62.94 |
PEG ratio | -0.97 |
P/B ratio | 7.50 |
P/S ratio | 3.81 |
Company profile
Cambi ASA bietet thermische Hydrolyse, fortschrittliche anaerobe Vergärung und Biogaslösungen für die Behandlung von Klärschlamm und organischen Abfällen in Europa, den Vereinigten Staaten, Asien, Afrika und Ozeanien. Das Unternehmen bietet außerdem Prozessaktualisierung und -unterstützung, Probentests, Front-End-Engineering-Studien, technische Planung, Installation, Inbetriebnahme, Ramp-up von Faulbehältern, Schulungslösungen, Standort- und Fernsupport, Ersatzteile, Optimierung sowie Upgrades und Erweiterungen an. Das Unternehmen wurde 1989 gegründet und hat seinen Hauptsitz in Asker, Norwegen.
| Name | CAMBI ASA NK -,02 |
| CEO | Per Audun Lillebo |
| Headquarters | Asker,
ak Norway |
| Website | |
| IPO | 02/09/2021 |
| Employees | 190 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Osl | CAMBI.OL |
Frankfurt | 3W7.F |
Düsseldorf | 3W7.DU |
London | 0ABM.L |
München | 3W7.MU |
Discover assets
Shareholders of CAMBI ASA NK -,02 also invest in the following assets
